Clinical Trial Update: Oral Miltefosine Plus Topical Imiquimod to Treat Cutaneous Leishmaniasis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating oral miltefosine in combination with topical imiquimod for cutaneous leishmaniasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Leishmaniasis

Drugs mentioned

• Imiquimod (imiquimod)
• Miltefosine (miltefosine)

Snippet

Sponsor: Foundation Fader | Conditions: Cutaneous Leishmaniasis | Phase 2 | Status: COMPLETED